Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Home
About Us
Meet the Team
Product
Blog
Careers
Contact Us
Client Login
Nephron Blog
December 6, 2023
Protected: Nephron Bioprocessing Industry KOL Call – Dec. 5th – REPLAY
November 29, 2023
Protected: Nephron Lab/Dx Updates Post-AMP 2023 – REPLAY
November 16, 2023
Protected: 2024 Elections & Impact on Health Subsectors – Nov. 15th – REPLAY
November 7, 2023
Protected: NGS Industry KOL Call – Nov 6th – REPLAY
October 30, 2023
Protected: TCT Takeaways Call with Leading Cardiologists – Oct. 30th – REPLAY
October 12, 2023
Broader Impact of Adoption of GLP-1 Therapy for Weight Loss
October 6, 2023
Protected: Life Science Tools Industry Update – Oct. 5th – REPLAY
October 5, 2023
Protected: Survey Says: PBM Profit Drivers Continue to Shift – Sept. 22nd – REPLAY
September 18, 2023
Trends in Profitability and Compensation of PBMs and PBM Contracting Entities
September 11, 2023
Protected: Nephron Call – CVS Launches Cordavis Biosimilar Subsidiary – Sept. 8th – REPLAY
September 11, 2023
Protected: KOL Call – Impact of Medicaid Redeterminations – Sept. 8th – REPLAY
September 8, 2023
Protected: China Tools & Dx Market Update KOL Call – Sept. 8th – REPLAY
August 18, 2023
Protected: Renal Denervation: What to Expect from FDA Advisory Panel & Reimbursement Outlook – Aug 18th – REPLAY
August 18, 2023
Protected: Market Access Strategies – IQVIA & UPMC Health Plan – Aug 17th – REPLAY
August 18, 2023
Protected: KOL Views on Clinical Trials for CROs & Tools – Aug 16th – REPLAY
Posts navigation
1
2
…
15
>>